-
1
-
-
0005360283
-
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus
-
World Health Organization Consultation. .
-
World Health Organization Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO Consultation Geneva 1999.
-
(1999)
Report of a WHO Consultation Geneva
-
-
-
3
-
-
0031678614
-
1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate
-
1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care 1998; 21: 1612-7
-
(1998)
Diabetes Care
, vol.21
, pp. 1612-1617
-
-
Wolever, T.M.S.1
Chiasson, J.L.2
Josse, R.G.3
-
4
-
-
18144415490
-
Should minimal blood glucose variability become the gold standard of glycemic control?
-
Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? Diabetes Complications 2005; 19: 178-81.
-
(2005)
Diabetes Complications
, vol.19
, pp. 178-181
-
-
Hirsch, I.B.1
Brownlee, M.2
-
5
-
-
73449130201
-
Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25or twice daily human insulin mix 30/70
-
Li Y, Li Q, Li CJ, Wang CJ, Zheng YM, Issa M, et al. Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25or twice daily human insulin mix 30/70. Chin Med J 2009; 122: 2540-6.
-
(2009)
Chin Med J
, vol.122
, pp. 2540-2546
-
-
Li, Y.1
Li, Q.2
Li, C.J.3
Wang, C.J.4
Zheng, Y.M.5
Issa, M.6
-
6
-
-
33144478510
-
The inhibitory effects of berry polyphenols on digestive enzymes
-
McDougall GJ, Stewart D. The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors 2005; 23: 189-95.
-
(2005)
Biofactors
, vol.23
, pp. 189-195
-
-
McDougall, G.J.1
Stewart, D.2
-
7
-
-
0037097039
-
STOP-NIDDM trial research group. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data
-
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. STOP-NIDDM trial research group. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Lancet 2002; 359: 2072-7.
-
(2002)
Lancet
, vol.359
, pp. 2072-2077
-
-
Chiasson, J.L.1
Josse, R.G.2
Gomis, R.3
Hanefeld, M.4
Karasik, A.5
Laakso, M.6
-
8
-
-
59249088492
-
Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes
-
Tibaldi J. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes. South Med J 2009; 102: 60-6.
-
(2009)
South Med J
, vol.102
, pp. 60-66
-
-
Tibaldi, J.1
-
9
-
-
0025823825
-
Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with dine
-
Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 1991; 14: 732-7.
-
(1991)
Diabetes Care
, vol.14
, pp. 732-737
-
-
Hanefeld, M.1
Fischer, S.2
Schulze, J.3
Spengler, M.4
Wargenau, M.5
Schollberg, K.6
-
11
-
-
33845996154
-
Standards of medical care in diabetes-2007
-
American Diabetes Association.
-
American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007; 30(Suppl 1): S4-S41.
-
(2007)
Diabetes Care
, vol.30
, Issue.SUPPL. 1
-
-
|